CAIRO, Stefano Enrico
 Distribuzione geografica
Continente #
NA - Nord America 3.392
AS - Asia 1.820
EU - Europa 673
SA - Sud America 363
AF - Africa 65
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.316
Nazione #
US - Stati Uniti d'America 3.321
SG - Singapore 706
CN - Cina 410
BR - Brasile 310
VN - Vietnam 225
HK - Hong Kong 161
DE - Germania 124
UA - Ucraina 102
SE - Svezia 85
GB - Regno Unito 84
TR - Turchia 80
IT - Italia 74
FR - Francia 53
JP - Giappone 49
RU - Federazione Russa 44
IN - India 41
FI - Finlandia 35
CA - Canada 32
MX - Messico 32
ID - Indonesia 27
BD - Bangladesh 26
ZA - Sudafrica 22
AR - Argentina 17
MA - Marocco 17
PK - Pakistan 16
ES - Italia 15
IQ - Iraq 12
PL - Polonia 12
EC - Ecuador 11
NL - Olanda 10
UZ - Uzbekistan 9
AT - Austria 8
CO - Colombia 8
IR - Iran 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
KR - Corea 7
LT - Lituania 6
PH - Filippine 6
SA - Arabia Saudita 6
DZ - Algeria 5
EG - Egitto 5
NP - Nepal 5
IL - Israele 4
KE - Kenya 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
DO - Repubblica Dominicana 3
JO - Giordania 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
MG - Madagascar 2
MM - Myanmar 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KI - Kiribati 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TZ - Tanzania 1
Totale 6.316
Città #
Singapore 420
Ashburn 408
Fairfield 322
Woodbridge 286
San Jose 243
Beijing 159
Chandler 157
Houston 157
Santa Clara 154
Hong Kong 152
Jacksonville 132
Seattle 129
Ann Arbor 126
Wilmington 121
Cambridge 102
Ho Chi Minh City 76
New York 74
Dallas 71
Hanoi 50
Los Angeles 49
Tokyo 49
Izmir 47
Nanjing 37
Boardman 36
Dearborn 35
Council Bluffs 31
Lauterbourg 30
Princeton 29
São Paulo 29
Shanghai 28
Ferrara 22
Mexico City 22
Bremen 21
Montreal 20
San Diego 19
Jakarta 18
Falls Church 16
Orem 16
London 15
Munich 15
Brooklyn 14
Chicago 14
Da Nang 14
The Dalles 14
Augusta 13
Chennai 13
Nanchang 13
Stockholm 13
Phoenix 12
Rio de Janeiro 12
Johannesburg 11
Warsaw 11
Hebei 10
San Francisco 10
Ankara 9
Curitiba 9
Haiphong 9
Manchester 9
Milan 9
Moscow 9
Nuremberg 9
Tashkent 9
Atlanta 8
Columbus 8
Guangzhou 8
Poplar 8
Shenyang 8
Boston 7
Campinas 7
Des Moines 7
Jiaxing 7
Ardabil 6
Belo Horizonte 6
Denver 6
Frankfurt am Main 6
Hangzhou 6
Ninh Bình 6
Norwalk 6
Addison 5
Amsterdam 5
Baghdad 5
Biên Hòa 5
Brasília 5
Changsha 5
Fes 5
Guarulhos 5
Mumbai 5
Redwood City 5
Brno 4
Bến Tre 4
Cairo 4
Caracas 4
Casalecchio Di Reno 4
Charlotte 4
Guayaquil 4
Hefei 4
Helsinki 4
Lahore 4
Leawood 4
Mountain View 4
Totale 4.377
Nome #
Abstract P5-06-04: The PARP inhibitor niraparib demonstrated activity in patient-derived triple-negative breast cancer xenograft models with high homologous recombination deficiency (HRD) score 253
Early activation of IFN/STAT signaling in tumor cells of patient-derived triple negative breast cancer xenografts predicts tumor sensitivity to chemotherapy 247
Functional genomics of the B-box gene family reveals a possible role in subcellular compartmentalization 228
Functional characterization of the OFD1 protein reveals a nuclear localization and physical interaction with subunits of a chromatin remodeling complex 223
Activation of Wnt and Myc signaling in hepatoblastoma 221
Reprogramming of miRNA networks in cancer and leukemia 215
Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway? 211
Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress 209
CA3-Classification de l’hépatoblastome par l'étude en microarray du profil d’expression génétique 207
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 204
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 197
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts 194
How transient becomes stable: an epigenetic switch linking liver inflammation and tumorigenesis 193
The genomic landscape of hepatoblastoma and their progenies with HCC-like features 185
TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer 185
Preferential localization of tyrosine-phosphorylated paxillin in focal adhesions 180
The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) induces regression in papillary renal cell carcinoma patient-derived xenograft models 177
LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis 174
Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer 166
The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis 165
The tripartite motif family identifies cell compartments 165
The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription 163
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features 158
Myc target miRs and liver cancer: small molecules to get Myc sick 155
Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein 146
Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer 122
A KRAS-responsive long non-coding RNA controls microRNA processing 115
Patient-derived xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management 111
Targeting the Vav1/miR‐29b axis as a potential approach for treating selected molecular subtypes of triple‐negative breast cancer 110
Abstract B11: A panel of patient-derived xenografts for preclinical efficacy studies in various breast cancer molecular subtypes 100
Expression profiling and CGH array as prognostic tools in hepatoblastoma 96
Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties 93
null 83
Establishment and characterization of circulating tumor cell-derived xenografts in non-small cell lung cancer 81
SSEA4 AND ST3GAL2 AS CHEMOTHERAPEUTIC DRUG RESPONSE BIOMARKERS 81
Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype 80
Functional evaluation of interferon/STAT1 pathway activation in response to genotoxic treatment 79
null 76
A panel of pediatric liver cancer patient-derived xenografts to improve stratification of children with hepatoblastoma 75
The PARP inhibitor niraparib demonstrates robust activity in a subset of patient-derived triple-negative breast cancer xenograft models 57
Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model 49
Tbx3 is a downstream target of the Wnt/$\beta$-catenin pathway and a critical mediator of $\beta$-catenin survival functions in liver cancer 48
Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression 44
Understanding breast cancer resistance to chemotherapy: Characterization of cancer cell sub-populations in residual and relapsed tumors 44
Preclinical evaluation of the PARP inhibitor niraparib and cytotoxic chemotherapy alone or in combination in a panel of 25 triple-negative breast cancer PDX models: Relevance of BRCA mutations, HRD status and other biomarkers 43
Totale 6.408
Categoria #
all - tutte 29.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021155 0 0 0 0 0 0 0 0 0 44 79 32
2021/2022313 20 21 16 7 31 30 12 26 11 38 33 68
2022/2023361 30 33 27 36 70 45 11 29 43 5 20 12
2023/2024231 14 26 7 6 7 52 5 19 6 10 7 72
2024/2025960 21 14 60 20 124 72 61 72 167 94 171 84
2025/20262.500 265 113 247 280 449 158 412 139 223 214 0 0
Totale 6.408